QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice-Reference-Cited by-同舟云学术

QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice

Published:2019-11-01 Issue:11 Volume:139 Page:1427-1434
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

Aimono Yuka¹²,Kohyama Noriko¹,Kamoshida Toshiro³,Yamamoto Toshinori⁴,Kogo Mari¹

Affiliation:

1. Division of Pharmacotherapeutics, Department of Clinical Pharmacy, School of Pharmacy, Showa University

2. Department of Clinical Pharmacy, Hitachi, Ltd., Hitachi General Hospital

3. Department of Medical Gastroenterology, Hitachi, Ltd., Hitachi General Hospital

4. Showa University Medical Foundation

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/139/11/139_19-00019/_pdf

Reference26 articles.

1. 1) The Japan Society of Hepatology, “C gata kanen chiryou guideline (dai 6.2 ban),” p. 1: 〈https://www.jsh.or.jp/files/uploads/HCV_GL_ver6.2_v1.1.pdf〉, cited 28 December, 2018.

2. 2) The Japan Society of Hepatology, “Kangan hakusho 2015,” pp. 24-27: 〈https://www.jsh.or.jp/files/uploads/Liver%20Cancer%202015.pdf〉, cited 28 December, 2018.

3. 3) Afdhal N., Zeuzem S., Kwo P., et al., N. Engl. J. Med., 370, 1889-1898 (2014).

4. 4) Pharmaceuticals and Medical Devices Agency, Dear Healthcare Professionals Letter of Rapid Safety Communication BLUE LETTER 14-02: 〈https://www.pmda.go.jp/files/000147439.pdf〉, cited 28 December, 2018.

5. 5) Sainokami S., Hino K., Shimoda K., Niwa H., Jpn. J. Clin. Med., 52, 205-210 (1994).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy;European Journal of Hospital Pharmacy;2020-04-03